Neurontin Lawsuit | 2025 Latest Updates

Neurontin Lawsuit Overview

Neurontin (gabapentin) lawsuits center around severe skin reactions including Stevens-Johnson Syndrome (SJS) and Toxic Epidermal Necrolysis (TEN). Plaintiffs allege that Pfizer failed to adequately warn patients and doctors about these potentially life-threatening risks. Multiple cases have documented the link between Neurontin and these dangerous conditions, with mortality rates for TEN reaching as high as 50%. The FDA has previously required medication guides and labeling updates for antiepileptic drugs including gabapentin.

Latest Neurontin Lawsuit Updates

January 28, 2025 – Schmidt&Clark law firm continues to investigate Neurontin-induced Stevens-Johnson Syndrome cases across all 50 states, offering free consultations to affected patients.

August 1, 2024 – A 38-year-old woman developed Toxic Epidermal Necrolysis after taking an antiepileptic drug similar to Neurontin, highlighting the ongoing safety concerns with medications in this class. The case study revealed a 44.4% mortality rate among children under 12 who developed SJS or TEN [1].

August 2020 – Japanese Adverse Drug Event Report analysis (2004-2018) revealed that combining antiepileptic drugs significantly increases the risk of Stevens-Johnson Syndrome, raising additional concerns about Neurontin’s safety profile when used in combination therapy.

Related Article: Stevens-Johnson Syndrome Lawsuit Update

FDA Reports and Statistics

The FDA has documented multiple adverse events related to Neurontin (gabapentin) and other antiepileptic drugs in its Adverse Event Reporting System (FAERS):

• Cases of Neurontin-induced Stevens-Johnson Syndrome (SJS) have been documented, including a 2007 case report of a 68-year-old woman by the Korean Academy of Asthma, Allergy, and Clinical Immunology.
• Research indicates 80-90% of SJS and Toxic Epidermal Necrolysis (TEN) reactions occur within the first two months of antiepileptic drug therapy.
• Since 2008, the FDA has required manufacturers of antiepileptic drugs, including Neurontin, to include warnings about serious skin reactions such as SJS and TEN.
• Studies suggest that the HLA-B*1502 gene, common in Asian populations, significantly increases the risk of developing SJS when taking aromatic antiepileptic medications like carbamazepine, though evidence for Neurontin is less conclusive.

Neurontin Injuries & Side Effects

Neurontin (gabapentin) has been linked to serious, potentially life-threatening skin reactions and other side effects.

• Stevens-Johnson Syndrome (SJS): Painful rash that spreads and blisters, affecting less than 10% of body surface area, with symptoms including fever, sore throat, and painful blisters on skin and mucous membranes.
• Toxic Epidermal Necrolysis (TEN): More severe form of SJS, affecting over 30% of body surface with skin detachment, carrying a mortality rate of 25-50%.
• Permanent Vision Damage: Severe cases can lead to dry eyes, corneal scarring, or blindness if the eyes were affected.
• Respiratory Damage: Scarring in the airway causing chronic breathing difficulties and increased risk of infections.
• Psychological Effects: Anxiety, depression, or PTSD resulting from the trauma of severe illness.

Do You Qualify for a Neurontin Lawsuit?

You may qualify for a Neurontin lawsuit if:

• You were prescribed and took Neurontin (gabapentin)
• You developed Stevens-Johnson Syndrome (SJS) or Toxic Epidermal Necrolysis (TEN) after taking the medication
• Your condition required medical treatment or hospitalization
• You can provide medical documentation linking your injuries to Neurontin use

Evidence Required for a Neurontin Lawsuit

Strong evidence significantly improves your chances of a successful claim:

• Medical Records: Documentation of your SJS or TEN diagnosis and all treatments received
• Medication History: Proof of Neurontin prescription and usage, including dosage and duration
• Symptom Timeline: Detailed record showing when symptoms began in relation to Neurontin use
• Photographic Evidence: Images documenting skin lesions, blisters, and other visible effects
• Expert Testimony: Statements from medical professionals confirming the drug reaction

Damages You Can Recover

A successful Neurontin lawsuit may provide compensation for:

• Medical expenses, including hospitalization, specialist care, and ongoing treatments
• Lost wages and diminished earning capacity
• Pain and suffering from physical and emotional trauma
• Long-term care costs for permanent disabilities
• Punitive damages in cases of gross negligence

Some drugs have a strong association with triggering SJS, including:

• Antiepileptics: Carbamazepine, phenytoin, lamotrigine, phenobarbital.
• Antibiotics: Sulfonamides, penicillins, nevirapine.
• Other Common Medications: Allopurinol (gout treatment), NSAIDs, acetaminophen.

Statute of Limitations for Neurontin Lawsuits

Time limits for filing a Neurontin lawsuit vary by state, typically ranging from one to three years from either:

• The date of your SJS/TEN diagnosis, or
• The date you first suspected Neurontin caused your condition

Consulting with an experienced attorney as soon as possible is crucial to ensure you don’t miss your filing deadline.

Related Articles:

• Naprosyn Stevens-Johnson Syndrome Lawsuit Attorney
• Lamictal Stevens-Johnson Syndrome Litigation
• Flagyl Stevens-Johnson Syndrome

FAQs

1. How do I start a Neurontin Stevens-Johnson Syndrome lawsuit?

Contact an experienced attorney specializing in pharmaceutical litigation who can evaluate your case, gather necessary evidence, and file your claim within the statute of limitations.

2. What kind of compensation can I receive from a Neurontin lawsuit?

Compensation may include medical expenses, lost wages, pain and suffering, and long-term care costs. The amount depends on your specific injuries, treatment needs, and impact on quality of life.

3. How do I prove that Neurontin caused my Stevens-Johnson Syndrome?

Proving causation requires medical records documenting Neurontin use, expert testimony linking the medication to your condition, and evidence ruling out other potential causes.

4. Are there any costs associated with filing a Neurontin lawsuit?

Most pharmaceutical injury attorneys work on a contingency fee basis, meaning you pay nothing upfront and only pay legal fees if you win your case or receive a settlement.

5. How long do Neurontin lawsuits typically take?

The timeline varies based on case complexity, but most pharmaceutical lawsuits take 1-3 years from filing to resolution, with some settling earlier during negotiations.

6. Will I have to go to court for my Neurontin lawsuit?

Many pharmaceutical cases settle before trial, but preparation for court proceedings is important. Your attorney will guide you through all necessary steps regardless of whether your case goes to trial.

7. Can I join a class action lawsuit for Neurontin-induced SJS?

Individual lawsuits are more common for SJS/TEN cases due to the unique nature of each person’s injuries and circumstances, but your attorney can advise on the best approach for your situation.

See all related dangerous drug lawsuits our attorneys covered so far.

Take Action Now: Time-Sensitive Legal Claims

Time is limited to pursue legal action for Neurontin-related injuries. Many states only allow 1-3 years from the date of injury to file a claim, making it crucial to act quickly.

Schmidt&Clark, LLP offers:

• Free, confidential consultations with specialized pharmaceutical attorneys
• No upfront costs or fees for representation
• Payment only if we win your case or secure a settlement
• Nationwide representative with experience in all 50 states

Don’t delay seeking the justice and compensation you deserve for your Neurontin-related injuries.

[START YOUR FREE CASE REVIEW NOW]

Reference: 

[1] https://pmc.ncbi.nlm.nih.gov/articles/PMC11324585/